{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:57:39Z","timestamp":1784127459310,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972487"],"award-info":[{"award-number":["81972487"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271506"],"award-info":[{"award-number":["82271506"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["202104070680"],"award-info":[{"award-number":["202104070680"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["20253572"],"award-info":[{"award-number":["20253572"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ9408"],"award-info":[{"award-number":["2024JJ9408"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ70038"],"award-info":[{"award-number":["2022JJ70038"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ60053"],"award-info":[{"award-number":["2023JJ60053"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021JJ20039"],"award-info":[{"award-number":["2021JJ20039"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ81042"],"award-info":[{"award-number":["2025JJ81042"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ymthe.2025.10.042","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:36:24Z","timestamp":1761316584000},"page":"985-1008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC"],"prefix":"10.1016","volume":"34","author":[{"given":"Yuxin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyu","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-7316","authenticated-orcid":false,"given":"Yingying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.042_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2025.10.042_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061880","article-title":"LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer","volume":"15","author":"Tong","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2025.10.042_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102225","article-title":"Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells","volume":"14","author":"Camorani","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2025.10.042_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41422-023-00795-2","article-title":"Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial","volume":"33","author":"Liu","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2025.10.042_bib5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41418-023-01128-x","article-title":"PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2025.10.042_bib6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41551-021-00799-6","article-title":"Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells","volume":"5","author":"Xue","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2025.10.042_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004022","article-title":"CD4(+) T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1\/PD-L1 immunotherapy","volume":"10","author":"Xiao","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.042_bib8","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00262-020-02792-5","article-title":"Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC","volume":"70","author":"O'Melia","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2025.10.042_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79811","article-title":"VPS9D1-AS1 overexpression amplifies intratumoral TGF-beta signaling and promotes tumor cell escape from CD8(+) T cell killing in colorectal cancer","volume":"11","author":"Yang","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.10.042_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-021-01223-x","article-title":"HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2025.10.042_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41368-023-00216-5","article-title":"RGS12 represses oral squamous cell carcinoma by driving M1 polarization of tumor-associated macrophages via controlling ciliary MYCBP2\/KIF2A signaling","volume":"15","author":"Yuan","year":"2023","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.ymthe.2025.10.042_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12935-022-02570-6","article-title":"Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN\/PI3K\/AKT signaling pathway","volume":"22","author":"Shou","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ymthe.2025.10.042_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12967-023-03910-4","article-title":"CD206(+) tumor-associated macrophages interact with CD4(+) tumor-infiltrating lymphocytes and predict adverse patient outcome in human laryngeal squamous cell carcinoma","volume":"21","author":"Heng","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.10.042_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101647","article-title":"Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer","volume":"31","author":"Junior","year":"2023","journal-title":"Transl Oncol."},{"key":"10.1016\/j.ymthe.2025.10.042_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12964-022-00888-2","article-title":"Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/beta-catenin signaling","volume":"20","author":"Chen","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2025.10.042_bib16","article-title":"Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.042_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages","volume":"167","author":"Mills","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.10.042_bib18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.10.042_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060778","article-title":"Physiologically Based Pharmacokinetic Modelling of Cabozantinib to Simulate Enterohepatic Recirculation, Drug-Drug Interaction with Rifampin and Liver Impairment","volume":"13","author":"Gerner","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2025.10.042_bib20","first-page":"76","article-title":"Targeting RTKs\/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials","volume":"11","author":"Mehta","year":"2024","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.ymthe.2025.10.042_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052664","article-title":"Tamoxifen Exerts Anticancer Effects on Pituitary Adenoma Progression via Inducing Cell Apoptosis and Inhibiting Cell Migration","volume":"23","author":"Lv","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.10.042_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ccr.2011.03.003","article-title":"Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036","volume":"19","author":"Chan","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.10.042_bib23","article-title":"The conformational control inhibitor of tyrosine kinases DCC-2036 is effective for imatinib-resistant cells expressing T674I FIP1L1-PDGFRalpha","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.042_bib24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ijc.31915","article-title":"Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL\/MET","volume":"144","author":"Shen","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.042_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41419-022-05185-x","article-title":"Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop","volume":"13","author":"Shen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.10.042_bib26","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1158\/1535-7163.MCT-17-0241","article-title":"The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2(Hi) Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors","volume":"16","author":"Harney","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2025.10.042_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41419-018-0290-x","article-title":"Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization","volume":"9","author":"Weng","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.10.042_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004113","article-title":"Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2\/AKT\/mTOR signaling pathway","volume":"10","author":"Zhuo","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.042_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116932","article-title":"Recent advances in hematopoietic cell kinase in cancer progression: Mechanisms and inhibitors","volume":"176","author":"Zeng","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2025.10.042_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13130","article-title":"IL10 deficiency promotes alveolar enlargement and lymphoid dysmorphogenesis in the aged murine lung","volume":"19","author":"Malinina","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.ymthe.2025.10.042_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1898753","article-title":"Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs","volume":"10","author":"Oyarce","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2025.10.042_bib32","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.cmet.2022.08.016","article-title":"Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1","volume":"34","author":"Chen","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2025.10.042_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911210","article-title":"Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages","volume":"12","author":"Menga","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.10.042_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2003014118","article-title":"Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1","volume":"118","author":"Tsai","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.042_bib35","article-title":"Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2025.10.042_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2020.02.011","article-title":"Remodeling tumor immune microenvironment via targeted blockade of PI3K-gamma and CSF-1\/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy","volume":"321","author":"Li","year":"2020","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.10.042_bib37","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1021\/acs.molpharmaceut.3c00769","article-title":"M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy","volume":"20","author":"Sun","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2025.10.042_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s12276-024-01163-9","article-title":"Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.10.042_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.799428","article-title":"Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.042_bib40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/ICO.0000000000003309","article-title":"IDO Regulates Macrophage Functions by Inhibiting the CCL2\/CCR2 Signaling Pathway in Fungal Keratitis","volume":"42","author":"Yu","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ymthe.2025.10.042_bib41","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.7150\/jca.52315","article-title":"Vitamin E succinate exerts anti-tumour effects on human cervical cancer cells via the CD47-SIRPa pathway both in vivo and in vitro","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.042_bib42","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1172\/JCI96268","article-title":"Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy","volume":"128","author":"Jayaprakash","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.10.042_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ccell.2020.12.001","article-title":"Integrin alphavbeta6-TGFbeta-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer","volume":"39","author":"Bagati","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.10.042_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41419-024-07263-8","article-title":"Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)","volume":"16","author":"Chen","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.10.042_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2017.03.006","article-title":"Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression","volume":"31","author":"Poh","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.10.042_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1578","article-title":"Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer","volume":"14","author":"Cao","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.10.042_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112365","article-title":"VISTA deficiency exerts anti-tumor effects in breast cancer through regulating macrophage polarization","volume":"136","author":"Jin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2025.10.042_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011080","article-title":"Blockade of CLEVER-1 restrains immune evasion and enhances anti-PD-1 immunotherapy in gastric cancer","volume":"13","author":"Yu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.042_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410288","article-title":"Peptide-Drug Conjugate for Therapeutic Reprogramming of Tumor-Associated Macrophages in Breast Cancer","volume":"12","author":"Lepland","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.10.042_bib50","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2016.152710","article-title":"Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia","volume":"102","author":"Cortes","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2025.10.042_bib51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1078-0432.CCR-24-2464","article-title":"Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer","volume":"31","author":"Anampa","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.042_bib52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13046-025-03494-5","article-title":"CCT196969 inhibits TNBC by targeting the HDAC5\/RXRA\/ASNS axis to down-regulate asparagine synthesis","volume":"44","author":"Yuan","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:30:57Z","timestamp":1770222657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625008639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1525001625008639"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.042","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}